StockData
Oncotelic Therapeutics, Inc. logo

Oncotelic Therapeutics, Inc. (OTLC) stock

OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.02+0.00 (+11.45%)

Close on Oct 19, 2026Market cap $8.66MP/E 0.0Yield –

Oncotelic Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Oncotelic Therapeutics's price to sales ratio was 228.1× on Apr 30, 2024, against 6.8× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Apr 30, 2024228.1×+212.5
2021Apr 30, 202115.6×−19.0
2014Apr 30, 201434.6×+27.9
2013Oct 31, 20136.7×–

More Oncotelic Therapeutics figures

See a number that looks wrong?